摘要
目的探讨阿托伐他汀钙片联合心血管药物治疗冠心病的临床效果。方法抽取至该院就诊的冠心病患者92例(2016年7月—2017年7月),依照就诊的次序进行分组,每组46例。其中一组采取一般的心血管药物,另外一组加用阿托伐他汀钙片,对比两组治疗效果。结果治疗后实验组的TC[(5.12±0.41)mmol/L]、TG[(1.39±0.68)mmol/L]、LDL-C[(3.32±0.40)mmol/L]水平相比常规组明显较低,HDL-C[(1.58±0.33)mmol/L]水平相比常规组明显较高(P=0.000 0);实验组与常规组的治疗总有效率分别为95.65%与78.26%(P<0.05)。结论对冠心病患者采取阿托伐他汀钙片+心血管药物进行治疗便于改善血脂水平,值得实践推广。
Objective This paper tries to investigate the clinical effect of atorvastatin calcium tablet combined with cardiovascular drugs for coronary heart disease. Methods Totally 92 patients with coronary heart disease（from July2016 to July 2017） were enrolled in the hospital and were divided into groups according to the order of treatment, with46 cases in each group. One group took general cardiovascular drugs, while another group added atorvastatin calcium.The two groups of treatment were compared. Results The levels of TC [（5.12±0.41）mmol/L], TG [（1.39±0.68）mmol/L]and LDL-C [（3.32±0.40）mmol/L] in the experimental group were significantly lower than those in the conventional group, And the level of HDL-C [（1.58±0.33）mmol/L] was significantly higher than that of the conventional group（P=0.000 0）. The total effective rates of the experimental group and the conventional group were 95.65% and 78.26%, respectively（P〈0.05）. Conclusion The treatment of atorvastatin calcium tablets and cardiovascular drugs in patients with coronary heart disease can improve the blood lipid level and is worth practicing.
作者
陈拥军
CHEN Yong-jun(Internal Medicine Department,Qingyun Shangtang Town Center hospital,Dezhou,Shandong Province,253700 Chin)
出处
《系统医学》
2018年第3期40-42,共3页
Systems Medicine
关键词
冠心病
心血管药物
阿托伐他汀钙片
Coronary heart disease
Cardiovascular drugs
Atorvastatin calcium tablet
